The e-retailer will launch five to eight targeted microsites in 2010, including one potentially geared toward vitamins. All drugstore.com's microsites "will focus on attractive product categories with high margins," said CEO Dawn Lepore during an Oct. 20 third-quarter earnings call. The Bellevue, Wash., firm introduced 1www.sexualwellbeing.com in August and plans another microsite in 2009 (2"The Tan Sheet" Aug. 10, 2009). In the quarter ended Sept. 27, drugstore.com grew OTC net sales 16.5 percent to $71.3 million. Lepore highlighted vitamins and supplements, which grew 35 percent, and oral care, up 30 percent. Overall net sales jumped 10.2 percent to $96.8 million, though drugstore.com still reported a net loss of $1.6 million, compared to a net loss of $3.6 million in the year-ago quarter
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.